1.Zimmet P, Magliano DJ, Herman W, Shaw J. Diabetes: a 21st century challenge. The Lancet Diabetes & Endocrinology. 2014;2(1):56–64.
2.Al-Saeed AH, Constantino MI, Molyneaux L, D’Souza M, Limacher-Gisler F, Luo C, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care. 2016;39:823–9.
3.Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in Type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31(10):1985–91.
4.Ferris FL. How effective are treatments for diabetic retinopathy? Journal of the American Medical Association. 1993;269(10):1290–1.
5.Mitchell P, Foran S. Guidelines for the Management of Diabetic Retinopathy. Commonwealth of Australia: National Health and Medical Research Council; 2008. https://webarchive.nla.gov.au/awa/20141218020132/http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/di15.pdf. [Accessed 1 October 2019].
6.American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2019;42:S124-S38.
7.National Institute for health and Care Excellence. Type 2 diabetes in adults: management NICE guideline [NG28]. 2015. https://www.nice.org.uk/guidance/ng28/resources/type–2-diabetes-in-adults-management-pdf–1837338615493. [Accessed 23 October 2019].
8.Scanlon PH, Stratton IM, Leese GP, Bachmann MO, Land M, Jones C, et al. Screening attendance, age group and diabetic retinopathy level at first screen. Diabetic Medicine. 2016;33(7):904–11.
9.Wang SY, Andrews CA, Gardner TW, Wood M, Singer K, Stein JD. Ophthalmic screening patterns among youths with diabetes enrolled in a large US managed care network. JAMA Ophthalmology. 2017;35(5):432–8.
10.Diabetes Australia. Young Adults With Diabetes Needs Analysis. Canberra: Diabetes Australia, Canberra.; 2006. http://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/6321f173–1642–42ed–8501-e95dc1ffa189.pdf. [Accessed 5 June 2019].
11.Foreman J, Keel S, Xie J, Van Wijngaarden P, Taylor HR, Dirani M. Adherence to diabetic eye examination guidelines in Australia: the National Eye Health Survey. Medical Journal of Australia. 2017;206(9):402–6.
12.Lake AJ, Rees G, Speight J. Clinical and Psychosocial Factors Influencing Retinal Screening Uptake Among Young Adults With Type 2 Diabetes. Current Diabetes Reports. 2018;18(41).
13.Williams AM, Muir KW, Rosdahl JA. Readability of patient education materials in ophthalmology: a single-institution study and systematic review. BMC Ophthalmol. 2016;16:133.
14.Muir KW, Lee PP. Health literacy and ophthalmic patient education. Survey of Ophthalmology. 2010;55(5):454–9.
15.Lawrenson JG, Graham-Rowe E, Lorencatto F, Rice S, Bunce C, Francis JJ, et al. What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis. Health technology assessment (Winchester, England). 2018;22(29):1–160.
16.MacLennan PA, McGwin G, Heckemeyer C, et al. Eye care use among a high-risk diabetic population seen in a public hospital’s clinics. JAMA Ophthalmology. 2014;132(2):162–7.
17.Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. British Medical Journal. 2008;337:a1655.
18.Lake AJ, Browne JL, Abraham C, Tumino D, Hines C, Rees G, et al. A tailored intervention to promote uptake of retinal screening among young adults with type 2 diabetes - an intervention mapping approach. BMC Health Services Research. 2018;18(1):396.
19.Lake AJ, Browne JL, Rees G, Speight J. What factors influence uptake of retinal screening among young adults with type 2 diabetes? A qualitative study informed by the Theoretical Domains Framework. Journal of Diabetes and its Complications. 2017;31(6):997–1006.
20.Lake AJ, Speight J. Evidence-based leaflet to promote uptake of retinal screening among young adults in Australia. Integrated care for diabetes and eye health: A global compendium of good practice. Melbourne, Australia: Global Diabetic Retinopathy Advocacy Initiative.; 2018.
21.Nguyen TT, Jayadeva V, Cizza G, Brown RJ, Nandagopal R, Rodriguez LM, et al. Challenging recruitment of youth with type 2 diabetes into clinical trials. Journal of Adolescent Health. 2014;54(3):247–54.
22.Browne JL, Nefs G, Pouwer F, Speight J. Depression, anxiety and self-care behaviours of young adults with Type 2 diabetes: Results from the International Diabetes Management and Impact for Long-term Empowerment and Success (MILES) Study. Diabetic Medicine. 2014;32(1):133–40.
23.Zeitler P, Chou HS, Copeland KC, Geffner M. Clinical trials in youth-onset type 2 diabetes: needs, barriers, and options. Current Diabetes Reports. 2015;15(5):1–8.
24.Solomon RL. An extension of control group design. Psychological Bulletin. 1949;46(2):14.
25.Spangenberg ER, Sprott DE, Knuff DC, Smith RJ, Obermiller C, Greenwald AG. Process evidence for the question–behavior effect: Influencing socially normative behaviors. Social Influence. 2012;7(3):211–28.
26.Johnson BT, Scott-Sheldon LAJ, Carey MP. Meta-synthesis of health behavior change meta-analyses. American Journal of Public Health. 2010;100(11):2193–8.
27.Australian Institute of Health and Welfare. Type 2 diabetes in Australia’s children and young people: a working paper. Canberra2014. http://www.aihw.gov.au/publication-detail/?id = 60129546361. [Accessed 5 June 2019].
28.Dallal GE. Randomization.com. 2019. http://www.randomization.com/. [Accessed 5 June 2019].
29.Hipwell AE, Sturt J, Lindenmeyer A, Stratton I, Gadsby R, O’Hare PO, et al. Attitudes, access and anguish: a qualitative interview study of staff and patients’ experiences of diabetic retinopathy screening. BMJ Open. 2014;4(12):e005498.
30.Kroenke K, Spitzer RL, Williams JBW. The Patient Health Questionnaire–2: Validity of a Two-Item Depression Screener. Medical Care. 2003;41(11):1284–92.
31.Cohen J. Statistical Power Analysis for the Behavioral Sciences: Burlington: Elsevier Science, 2013.; 2013.
32.Zhang X, Norris SL, Saadine J, Chowdhury FM, Horsley T, Kanjilal S, et al. Effectiveness of interventions to promote screening for diabetic retinopathy. American journal of preventive medicine. 2007;33(4):318–35.
33.Nadeau KJ, Anderson BJ, Berg EG, Chiang JL, Chou H, Copeland KC, et al. Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities. Diabetes Care. 2016;39(9):1635–42.
34.Müller A, Lamoureux E, Bullen C, Keeffe JE. Factors associated with regular eye examinations in people with diabetes: Results from the Victorian Population Health Survey. Optometry and Vision Science. 2006;83(2):96–101.
35.MacLennan P, McGwin G, Searcey K, Owsley C. Medical Record Validation of Self-Reported Eye Diseases and Eye Care Utilization Among Older Adults. Current Eye Research. 2013;38(1):1–8.
36.Calugi S, Dalle Grave R, Compare A, Dall’Aglio E, Petroni ML, Marchesini G. Weight loss and clinical characteristics of young adults patients seeking treatment at medical centers: Data from the QUOVADIS Study. Eating Weight Disord. 2012;17(4):e314-e9.
37.Leung AWY, Chan RSM, Sea MMM, Woo J. An overview of factors associated with adherence to lifestyle modification programs for weight management in adults. International journal of environmental research and public health. 2017;14(8).
38.Nanditha A, Ma RCW, Ramachandran A, Snehalatha C, Chan JCN, Chia KS, et al. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016;39(3):472–85.
39.Browne JL, Scibilia R, Speight J. The needs, concerns, and characteristics of younger Australian adults with type 2 diabetes. Diabetic Medicine. 2013;30(5):620–6.
40.Brouwer AM, Salamon KS, Olson KA, Fox MM, Yelich-Koth SL, Fleischman KM, et al. Adolescents and type 2 diabetes mellitus: a qualitative analysis of the experience of social support. Clinical Pediatrics. 2012;51(12):1130–9.
41.Zwarenstein M, Shiller SK, Croxford R, Grimshaw JM, Kelsall D, Paterson JM, et al. Printed educational messages aimed at family practitioners fail to increase retinal screening among their patients with diabetes: a pragmatic cluster randomized controlled trial [ISRCTN72772651]. Implementation Science. 2014;9(1):1–9.
42.Abraham C, Krahe B, Dominic R, Fritsche I. Do health promotion messages target cognitive and behavioural correlates of condom use? A content analysis of safer sex promotion leaflets in two countries. British Journal of Health Psychology. 2002;7:227–33.
43.Diabetes Australia. KeepSight. 2019. https://www.keepsight.org.au/. [Accessed 17 June 2019].
44.Conner M, Godin G, Norman P, Sheeran P. Using the question-behavior effect to promote disease prevention behaviors: two randomized controlled trials. Health Psychology. 2011;30(3):300–9.
45.Komiti A, Jackson HJ, Nankervis A, Conn J, Allan C, Judd F. An investigation of psycho-social factors associated with the uptake of pre-pregnancy care in Australian women with type 1 and type 2 diabetes. Journal of psychosomatic obstetrics and gynaecology. 2013;34(2):75–81.
46.Diabetes Victoria. Who’s looking after your eyes? Diabetes and eye health webinar. 2019. diabetesvic.org.au/eyes. [Accessed 22 May 2019].
47.Vision 2020 Australia. The case for an Australian Diabetes Blindness Prevention Initiative. 2017. http://www.vision2020australia.org.au/resources/australian-diabetes-blindness-prevention-initiative. [Accessed 1 October 2019].
48.Willis GB. Cognitive Interviewing: A Tool For Improving Questionnaire Design. 1 ed. California, USA: Sage Publications, Inc.; 2005. 334 p.
49.Fok CC, Henry D, Allen J. Maybe Small Is Too Small a Term: Introduction to Advancing Small Sample Prevention Science. Prevention Science. 2015;16 (Special section)(7):943–9.
50.Quay TA, Frimer L, Janssen PA, Lamers Y. Barriers and facilitators to recruitment of South Asians to health research: a scoping review. BMJ Open. 2017;7(5):e014889.